# FDA recall D-0016-2017

> **Leiter's Compounding** · Class II · drug recall initiated 2016-09-20.

## Product

Moxifloxacin 1 mg/mL in Sterile Balanced Salt Solution (BSS)  Intravitreal Injection, 1 mL Total Volume in a 2 mL Vial, Compounded by Leiter's Compounding, San Jose, CA --- NDC 70360-003-35

## Reason for recall

Lack of Assurance of Sterility; all compounded products within expiry produced using recalled filters

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0016-2017
- **Recalling firm:** Leiter's Compounding
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-09-20
- **Report date:** 2016-10-19
- **Termination date:** 2017-05-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** San Jose, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0016-2017

## Citation

> AI Analytics. FDA recall D-0016-2017. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0016-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*